In the last decade several different devices adapting ultraviolet-C (UV-C)-based technology for sanitization or disinfection purposes were placed to market with the scope of irreversibly inactivating viruses on PPE (e.g. re-usable goggles and facemasks), re-usable medical devices, pre-cleaned food and biopharma manufacturing surfaces, food packaging and more. In the context of the COVID-19 pandemic, several UVC devices employed to sanitize consumer products, have rapidly entered the market.
It is imperative that these devices have proven efficacy so it's therefore necessary to establish reproducible and reliable virucidal tests to challenge the efficacy of such devices.
The British standardization committee (BSI) recently published a standard (BS 8628:2022) in order to test UVC-based technology in a standardized manner. This is now the industry standard.
Eurofins BioPharma Product Testing in Italy within it's dedicated virucidal laboratory can perform the standard BS 8628 (according to EN 17272) and also can perform tailor-made tests in order to validate the surface virucidal efficacy of open and closed UVC products with different sized and complex designs, both for marketing claims and for regulatory purposes.
Our testing services help companies to ensure that the system employed at their facilities is both suitable for use and effective against viruses.
